Delivery Order SPE2DB25D3306-SPE2DB25FUCGL
- Not listed
- This is a $1,275.52 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The order is for 4,565,296,656 units of ZENPEP DR 10,000 UNIT CAPSULE 100S, a pharmaceutical product. The award has an ultimate completion date of July 31, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999 through...
- This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,199.06 contract is for the supply of 4,567,790,837 units of the drug ZENPEP (40,000 units per capsule, 100 capsules per bottle). The award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract...
- This is a $9,017.93 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,908,548 units of the drug ZENPEP DR 40,000 UNIT CAPSULE 100S. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $2,127.68 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distributor. The contract is for the delivery of 4,564,242,620 ZENPEP DR 15,000 UNIT CAPSULES 100S, a pharmaceutical product, with a performance period through April 12, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA valued at up to...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at ten thousand five hundred ninety-nine dollars and sixteen cents ($10,599.16) to Amerisourcebergen Drug Corporation for Zenpep DR 40,000 unit capsules. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania from September 11 through September 12, 2023. The delivery order is placed against an existing indefinite-delivery/indefinite-quantity contract vehicle to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,141.71 firm fixed-price delivery order covers the procurement of 4,564,544,240 units of the drug ZENPEP DR 20,000 in 100-count capsule containers. The contract has a completion date of May 9, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of ZENPEP DR 40,000 UNIT CAPSULE 100S. The order has a firm fixed price of $17,434.88 and a period of performance through May 30, 2025. The contract is not set aside and represents open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of 4,564,119,421 Zenpep DR 40,000 unit capsules in 100 count bottles. The contract award amount is $10,270.09 and has an ultimate completion date of April 1, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, which...
- This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,034.97, is for the supply of ZENPEP DR 40,000 UNIT CAPSULE 100S to support federal healthcare programs. The contract has a period of performance through May 14, 2024 and does not have a set-aside designation. AmerisourceBergen holds a $999,999,999...
- This federal contract award is a delivery order valued at $11,787.39 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the supply of ZENPEP DR 40,000 UNIT CAPSULE 100S, a medical product, with a period of performance through February 25, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA...
- SPE2DB25D3306Indefinite Delivery Contract
- SPE2DB25D3306-SPE2DB25FUCGLDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,406.60 to AmerisourceBergen Drug Corp for ZENPEP (pancrelipase) 40,000 unit capsules in quantities of 100 per bottle. This competitive award, issued on July 18, 2025, with an ultimate completion date of July 21, 2025, represents a firm fixed-price delivery order with no set-aside designation. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, the company's corporate headquarters and a major distribution hub for federal pharmaceutical procurement. This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications, medical devices, and healthcare commodities to support military and federal healthcare programs worldwide. ZENPEP, a pancreatic enzyme replacement therapy, aligns with the company's extensive portfolio of specialty medications and therapeutics delivered through the DLA's Medical Supply Chain to support Defense Health Agency operations, the U.S. Coast Guard, and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 7/18/25 |